Dr. Foluso N. Ogunleye, MD

Dr. Ogunleye practices at The Oncology Institute - Downey Radiation Oncology in Cerritos, California.

Dr. Ogunleye's NPI, 1972766772, was assigned on July 2, 2008. Dr. Ogunleye graduated from University of Benin Faculty of Medicine in 2001. Dr. Ogunleye's Nevada license number on file is 19016.

Dr. Ogunleye's primary practice is The Oncology Institute - Downey Radiation Oncology, at 18000 Studebaker Rd, Cerritos, CA 90703 in Los Angeles County. The practice phone is (310) 945-8112.

Dr. Ogunleye's primary practice is The Oncology Institute - Downey Radiation Oncology in Cerritos, California. Dr. Ogunleye is also affiliated with Temecula Valley Hospital. The medical group on file is The Oncology Institute of Hope and Innovation. Dmand AI also links Dr. Ogunleye to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ogunleye practices, 3 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Ogunleye's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Ogunleye is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Ogunleye's licenses on file in 8 states: Nevada, Arizona, California, Michigan, Georgia, Illinois, Iowa and Rhode Island.

Dmand AI lists breast cancer, chronic anemia, lung cancer, neutropenia, prostate cancer and purpura and thrombocytopenia among the conditions Dr. Ogunleye treats.

CMS data shows 1,191 Medicare services from Dr. Ogunleye across 9 procedure codes in 2024, for 109 Medicare patients. Medicare paid $25,346 for them. Every service was in an office.

CMS counts 109 Medicare patients who saw Dr. Ogunleye in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 17% are also on Medicaid. Their average risk score is 1.98, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ogunleye's median patient age at 67, with 63% women.

In 2024, Dr. Ogunleye wrote 1,460 Medicare Part D claims for 279 patients. 69% of them were for generic drugs. CMS names the drug for 1,299 of them, across 37 drugs with 11 or more claims each, at $6,027,606 in total drug cost. In 2023, CMS named 1,160 claims across 33 drugs.

Dr. Ogunleye accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Ogunleye as offering telehealth.

Dmand AI links 7 papers to Dr. Ogunleye, published from 2016 to 2018. 2017 was the busiest year, with 3. Dr. Ogunleye has published most often in J Oncol Pract. Dr. Ogunleye's most frequent co-authors are Marianne T. Huben, DO, Zhou Yu and Leann Michelle Blankenship, MD.

CMS Open Payments shows 620 general payments to Dr. Ogunleye from 70 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $2,096.

Dr. Ogunleye graduated from University of Benin Faculty of Medicine in 2001. Dr. Ogunleye is a member of ACP, AMA, ASCO, ASH and SHM.

Dr. Ogunleye is in network with 16 carriers, including Excellus BlueCross BlueShield, United Healthcare and Cigna. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.